Futura Medical Share Price (FUM)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Futura Medical	LSE:FUM	London	Ordinary Share	GB0033278473	ORD 0.2P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	-0.70p	-2.37%	28.80p	359,683	15:29:50

Bid Price		Offer Price	High Price	Low Price	Open Price
28.10p		29.50p	29.50p	28.15p	29.50p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	0.36	-4.84	-3.23		34.8

Related Shares
GlaxoSmithKline (GSK), AstraZeneca (AZN), Geiger Count. S (GCS), Port Erin (PEBI)

Futura Medical (FUM) Latest News

Futura Medical News

Date	Time	Source	Headline
23/7/2018	12:25	ALNC	Futura Medical UK Partner Files Marketing Application With Regulator
23/7/2018	08:10	ALNCF	Alliance News Flash Headline
23/7/2018	07:00	UKREG	Futura Medical PLC TPR 100: UK Regulatory Submission
13/6/2018	18:22	UKREG	Futura Medical PLC Result of AGM
13/6/2018	12:36	ALNC	Futura Says Licensing Of Erectile Dysfunction Gel Remains Top Priority
13/6/2018	07:01	UKREG	Futura Medical PLC AGM Statement
31/5/2018	18:20	UKREG	Futura Medical PLC Total Voting Rights
30/5/2018	10:20	UKREG	Futura Medical PLC Block Listing Interim Review
25/5/2018	07:01	UKREG	Futura Medical PLC Application for Block Listing
27/4/2018	17:11	UKREG	Futura Medical PLC Notification of Major Interest in Shares

More Futura Medical News

Futura Medical Takeover Rumours

Futura Medical (FUM) Share Charts

1 Year Futura Medical Chart

1 Month Futura Medical Chart

Intraday Futura Medical Chart

Futura Medical (FUM) Discussions and Chat

Futura Medical Forums and Chat

Date	Time	Title	Posts
17/8/2018	14:46	FUTURA a winner for 2015	4,436
21/3/2018	09:19	www.bluediamondcondom.com	56
02/12/2016	13:27	FUM delivering on sex,pain and rock'n'roll	11,414
21/6/2016	08:43	fum reality	1
07/11/2014	12:19	fum	-

Add a New Thread

Futura Medical (FUM) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2018-08-17 14:29:41	28.30	10,000	2,830.00	O
2018-08-17 13:51:08	28.30	10,000	2,830.00	O
2018-08-17 13:48:52	28.30	1,725	488.18	O
2018-08-17 13:22:34	28.13	2,000	562.50	O
2018-08-17 12:40:38	28.30	566	160.18	O

View all Futura Medical trades in real-time

Futura Medical (FUM) Top Chat Posts

Date	Subject
18/8/2018 09:20	Futura Medical Daily Update: Futura Medical is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 29.50p. Futura Medical has a 4 week average price of 27.25p and a 12 week average price of 27.25p. The 1 year high share price is 49.50p while the 1 year low share price is currently 21.50p. There are currently 120,696,002 shares in issue and the average daily traded volume is 140,262 shares. The market capitalisation of Futura Medical is £34,760,448.58. Read Full Thread Reply
03/8/2018 12:02	greedfear: “J777J - 11 Apr 2018 - 15:18:09 - 4070 of 4417 FUTURA a winner for 2015 - FUM Thanks for that. Despite recent share price weakness we see the uber bullish inverted head and shoulders pattern still in tact. This signals sharply higher share price.” And thh Read Full Thread Follow Reply
20/7/2018 18:42	pennywise: It could be argued that the touch paper is already lit and is smouldering albeit slowly at this point. At 31 Dec. 2017 there was £8.36m cash or cash equivalent showing on the balance sheet. The 2017 loss was £4.8m and in 2018 it is unlikely that the current income rate will give a higher yearly income. The development costs are likely to be higher in 2018. All of which points to a 2018 cash burn well in excess of £4.8m. This leaves two alternatives for salvation. Either quickly find a development partner who will fund the development costs. This may be difficult as history shows over many many years there have been unconsumated flirtations with most of the big players. Or try to raise further funds by dangling yet again some juicy carrots. This may not work as it is soon after the last in-gathering of cash. We can all try to re-assure each other by saying 'look at the rewards there will be one day'. Perhaps we should substitute might for will. FUM had £37m of accumulated losses at the end of 2017. Many of us have over the years been tempted to say 'the share price is currently very low I can average down'. Some have successfully sold at a profit but many of us have held on for the gold at the end of the rainbow. Perhaps if we see the price falling further, before we buy more, we should say 'my holding is 40,000 @ 25p, do I really want to keep £10,000 invested here'. The problem is many of us have held too long and lost too much. Me, I am half tempted to leave it where it is but write it off in my mind and if one day it all comes right I will be pleasantly surprised. What I will not do is buy more to bring my cost average down nor will I listen to unsubstantiated comments on this board that there are unlimited gains just around the corner. I hope Mr Barder achieves his dream before he retires and I hope that there will be solid eveidence of success soon, not for his sake but for mine and all other small shareholders, especiaaly those who have shown many years of patience. But if it goes boom it goes boom. Read Full Thread Follow Reply
05/6/2018 10:12	martinelwick: Good morning,I will not be able to attend the forthcoming AGM,but would like you to please address my following concerns,at the meeting.1.Why do think, given the potential for the ED treatment,that you keep stating,the share price is only 37p as I write.2.You have had two institutional investor presentations in the last couple of years,but failed to attract a single new investor.Why do you think this is?.Is it the product,the business model,or little faith in your management team to deliver,or perhaps a combination of all three.3.Why over the 10 years that I have been invested in FUM you have lost 4 license Partnerships4. Who was responsible for the 2 year shelf life debacle.This must surly have been a factor in the return of the last license.5. Why are we still waiting for regulatory approval re the shelf life?6.Why are we not selling in Holland and Belgium any longer.7 Why do we have complete radio silence concerning the pain relief portfolio.8.why has FUM consistently failed to meet promised timelines e.g. med 2002 deal by end of 2017.Its now June 2018.9.Do you concede that ,yes you have some very good potential products,but due to miss management we are still years away from any meaningful commercial achievement.Yours Martin Elwick. Read Full Thread Follow Reply
10/5/2018 10:01	rrr: toadhall, People have been saying that here for years. One day it may come true. Meanwhile, some people, including myself, understandably use this board to express their frustrations at serial failures to deliver, and serious setbacks. Before anyone complains that myself and others are doing down our own company, yes it's true we're being critical - but not without reason - but there's no harm in letting off steam, I'm sure what a handful of people say here has no bearing on the share price. For that to rise we need sustained good news with money attached. In the other direction, people write as you did, encouragingly. It was said here four or five weeks ago by someone that the share price would be 'in the stratosphere' quite soon (if I recall correctly). No harm done, but saying it hasn't made it happen either. rrr Read Full Thread Follow Reply
06/4/2018 15:32	lbo: The share price was falling this morning since before the AGM announcement. If Mr Barder does not come good on his most recent promises before the AGM and get the share price back above the last placing price then his tenure like the share price should should also be falling at the AGM. Read Full Thread Follow Reply
02/3/2018 15:12	j777j: Something for the weekend courtesy Gold dust on lse goldust881,179 posts Potential share price for Futura ? What is the future for Futura's share price. I have detailed below, from info in the results and more particularly from the webcast presentations what news Futura expects to announce during 2018, of which there is quite a lot that will affect the share price. MED2000-Securing of major commercial deal. CSD500-Reasignment of Rights for most of Europe and USA CSD500-Launch in 6 more countries and possibly up to 13. TPR100 & TIB200 -securing of further deals in USA/Europe. So what about the share price. Clearly there is massive potential if all the products end up all on sale at once but leading up to that point I think that announcements of each of the above this year will increase the share price as each one will confirm that progress is being made, some more than others. Clearly with any deal being announced one can expect upfront deal fees which can be substantial and this is what Futura expect as they stated at the results seminar they have no need to raise further cash. Looking at other company deals in these sectors the total upfront fees could easily be in the ?25-40 million range. So what could Futura be worth in a couple of years time. From global sales figures provided by Futura we have the following potential for Futura's market share and earnings. MED 2000 ($1 billion per annum)= ?800 million say @5% royalty is ?40 million pa TPR100 & TIB200 (1/2 billion per annum)=?400 million say @5% royalty is ?20 million pa CSD500 @10% market share of a $6billion pa market is $600 million=?450 million @ 5% royalty rate is ?9 million per annum. That totals to ?69 million per annum. That's the potential. So with an income of that size with minimal overheads the company on a p/e of 10 % would be valued at ?690 million or ?5.56 per share Current company value @ 47p today is appx 57million So the potential is 10 times the current share price. With lots of news this year we could easily see the share price double up with the newsflow and a big bucks rise coming after the current MED 2000 trial results due shortly. News may come at any time so it's a buy at this price now in my view with results due out on 14th March. If any of one of these major deals comes of the share price would double.. Clearly another investor who has done the maths and sees a ten bagger from here. Read Full Thread Follow Reply
02/1/2018 16:24	loobrush: from iii Back to 55p soon in my view-then upward Why is Futura share price rising. It seems to me that most have forgotten that Futura was around 55p when Church and Dwight decided to relinquish their CSD500 licences for a large part of Europe and the USA and that caused the drop from 55p to recent low of 25p. Whilst this was dissapointing news then, it may well turn out to a real Bonus as Church & Dwight were going nowhere with it. Those licences are now looking for a home and there could be a number of companies who are very interested in acquiring them. The recent share price increase could well be that a new deal for the licences is in the offing and if so, a share price rise back to 55pfor a start. Futura has already stated that it expects a deal to be signed around end March for their MED 2000 and if a deal is announced on these US and Europe licenses for CSD500 then Futura's share price may well reach a new high in the 90p plus area. Just a thought, maybe someone will take up CSD500 and Med 2000 for over the counter use-would be a good combination. Or maybe it all goes to a company selling online. Lets see Read Full Thread Follow Reply
07/6/2017 09:33	mikethebike4: james 'There will also be many new launches of the condom within the next 6 months which will help with the profile and see FUM Share price rocket....so the next 6 months are most interesting and the best time to be in here. - I have seen this written so many times over the last few years - I will be so shocked when it actually happens I will probably climax on the spot without the aid of Blue Diamond ! - 18 months product is already available from TTK in Asia - why they did not submit for regulatory approval at the same time in Europe I do not know - however I am expecting an announcement by the BoD so that the AGM is not a 'damp squib' MTB4 Read Full Thread Follow Reply
06/6/2017 22:59	jamesd888: There will also be many new launches of the condom within the next 6 months which will help with the profile and see FUM Share price rocket....so the next 6 months are most interesting and the best time to be in here. Read Full Thread Follow Reply
27/3/2017 11:41	loobrush: from iii What is the future for Futura's share price. I have detailed below, from info in the results and more particularly from the webcast presentation (which not many may have seen-but now available on their website) what news Futura expects to announce during 2017, of which there is quite a lot. MED2000-Securing of major commercial deal. CSD500-Church & Dwight launch in selected markets(probably UK, France & Germany ) CSD500-Launch in 6 more countries and possibly up to 13. TPR100 & TIB200 -securing of further deals in USA/Europe. So what about the share price. Clearly there is massive potential if all the products end up all on sale at once but leading up to that point I think that announcements of each of the above this year will increase the share price as each one will confirm that progress is being made, some more than others. Clearly with any deal being announced one can expect upfront deal fees which can be substantial and this is what Futura expect as they stated at the results seminar they have no need to raise further cash. Looking at other company deals in these sectors the total upfront fees could easily be in the £25-40 million range. So what could Futura be worth in a couple of years time. From global sales figures provided by Futura we have the following peak potential for Futura's market share and earnings. MED 2000 ($1 billion per annum)= £800 million say @5% royalty is £40 million pa TPR100 & TIB200 (1/2 billion per annum)=£400 million say @5% royalty is £20 million pa CSD500 @10% market share of a $6billion pa market is $600 million=£450 million @ 5% royalty rate is £9 million per annum. That totals to £69 million per annum. That's the peak potential. Lets discount that by 1/2 that gives £34.5 million per annum. So with an income of that size with minimal overheads the company on a p/e of 8 would be valued at £552 million or 460p per share Current company value@53p is £63million So the potential is 9 times the current share price. With lots of news this year we could easily see the share price double up with the newsflow and big bucks coming after the MED 2000 trial results in a year or so. Price may drift a bit before the first news but as news may come at any time so it's a hold or buy at this price in my view. Also there may be a surprise announcement of a new product(s) as they are working on this at the moment. Read Full Thread Follow Reply

Futura Medical share price data is direct from the London Stock Exchange

add chat code

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:41 V: D:20180818 12:22:16